Stem Cell Manufacturing Technology
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT02923375
A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 1, 2017
Completion: Jun 30, 2020
NCT04537351
The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause
Start: Aug 24, 2020
Completion: May 18, 2022
NCT05165628
Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers
Start: Jan 4, 2022
Completion: Sep 24, 2024
NCT05643638
A Study of CYP-001 in Combination with Corticosteroids in Adults with High-risk AGvHD
Phase: Phase 2
Start: Mar 4, 2024
Completion: Jun 30, 2027
Loading map...